HHS Secretary Robert F. Kennedy Jr. remains securely in his role over a year after narrow Senate confirmation, driving trader consensus at 76% against departure by December 31, 2026, amid a stable tenure despite persistent controversies. Recent developments include a February leadership overhaul he initiated—replacing deputies like Jim O'Neill—while unveiling 2026 budget plans and new programs on homelessness and addiction. A March federal judge injunction halted vaccine schedule changes, prompting a pre-midterm April shift to low-risk messaging on vaccines per internal memos. No public statements from the White House or Kennedy signal resignation or firing, with ongoing FDA reevaluations like peptides bolstering his policy momentum ahead of November midterms.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयाAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
बाज़ार खुला: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...HHS Secretary Robert F. Kennedy Jr. remains securely in his role over a year after narrow Senate confirmation, driving trader consensus at 76% against departure by December 31, 2026, amid a stable tenure despite persistent controversies. Recent developments include a February leadership overhaul he initiated—replacing deputies like Jim O'Neill—while unveiling 2026 budget plans and new programs on homelessness and addiction. A March federal judge injunction halted vaccine schedule changes, prompting a pre-midterm April shift to low-risk messaging on vaccines per internal memos. No public statements from the White House or Kennedy signal resignation or firing, with ongoing FDA reevaluations like peptides bolstering his policy momentum ahead of November midterms.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न